ACTA1 and renal fibrosis: At the same time, STAT3 can promote the high expression of α-SMA and fibronectin, which promote the development of renal fibrosis in CKD, a process that can be alleviated by the specific STAT3 signaling pathway inhibitors AG490 or TSA (Pang et al., 2009).